Pursuant to Regulation 30 and Para (A) of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Epigral has informed that the Company is having meeting with Analyst / Investor ‘UTI Asset Management Company’ on 16th January, 2026 (One-on-One) through Video Conferencing (V.C.). The latest Earnings Presentation and Corporate Presentation to be discussed have already been placed on the website of the Company; www.epigral.com. No unpublished price sensitive information will be shared/discussed in the meeting with the Investors.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| BASF India | 3685.40 |
| Tata Chemicals | 709.00 |
| SRF | 2479.95 |
| Pidilite Inds. | 1398.20 |
| Deepak Nitrite | 1621.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: